Prognostic value of soluble ST2 in an unselected cohort of patients admitted to an intensive care unit — The Linz Intensive Care Unit (LICU) study
- 22 March 2012
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 413 (5-6) , 587-593
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The IL-33/ST2 pathway — A new therapeutic target in cardiovascular diseasePharmacology & Therapeutics, 2011
- High-Sensitivity ST2 for Prediction of Adverse Outcomes in Chronic Heart FailureCirculation: Heart Failure, 2011
- Disease-associated functions of IL-33: the new kid in the IL-1 familyNature Reviews Immunology, 2010
- Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma — The Presage™ ST2 assayClinica Chimica Acta, 2009
- The IL-33/ST2 pathway: therapeutic target and novel biomarkerNature Reviews Drug Discovery, 2008
- Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart FailureJACC, 2008
- IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated CytokinesImmunity, 2005
- Serum Levels of the Interleukin-1 Receptor Family Member ST2 Predict Mortality and Clinical Outcome in Acute Myocardial InfarctionCirculation, 2004
- Identification of Serum Soluble ST2 Receptor as a Novel Heart Failure BiomarkerCirculation, 2003
- Different promoter usage and multiple transcription initiation sites of the interleukin‐1 receptor‐related human ST2 gene in UT‐7 and TM12 cellsEuropean Journal of Biochemistry, 1999